JPET Introducing ALZET?ew Model 2006 Pump

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Slotkin, T. A.
Right arrow Articles by Distefano, V.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Slotkin, T. A.
Right arrow Articles by Distefano, V.
Journal of Pharmacology And Experimental Therapeutics, Vol. 174, Issue 3, 456-462, 1970
Copyright © 1970 by American Society for Pharmacology and Experimental Therapeutics


A MODEL OF HARMINE METABOLISM IN THE RAT

Theodore A. Slotkin 1 and Victor Distefano 1

1 Department of Pharmacology, University of Rochester, Rochester, New York

Previous work from this laboratory has shown that the urinary metabolites of harmine (I) in the rat are harmol (II), harmol glucuronide (III) and harmol sulfate (IV); the rate-limiting step in harmine metabolism is first order with respect to the amount of harmine remaining in the body and occurs before the conjugation reactions. In the present study, biliary and urinary levels of the metabolites were determined after an i.v. dose of 5 mg/kg of I to rats; tissue levels of I were determined over a four-hour period. Metabolites were separated by paper chromatography conjugates were hydrolyzed with beta-glucuronidase-aryl sulfatase and the concentrations of I and II were determined by quantitative fluorometry. More than 99% of the dose was recovered; 73% was in the bile and 26% was in the urine. Nearly 70% was excreted in the first four hours. Seventy-seven percent was excreted as IV, 21% as III and 1% as I and II. Excretion of IV leveled off after eight hours, whereas excretion of III accelerated, probably due to sulfate depletion. The excretion curve indicated that two compartments contributed to the rate-limiting step. The levels in I in muscle corresponded to one of these compartments, and the levels in the other tissues corresponded to the second compartment. With the experimental data, a model of harmine metabolism was constructed which gave theoretical excretion curves which agreed with the experimental values to within 5%.

Submitted on September 8, 1969
Accepted on May 12, 1970




This article has been cited by other articles:


Home page
J. Pharmacol. Exp. Ther.Home page
A.-M. Yu, J. R. Idle, K. W. Krausz, A. Kupfer, and F. J. Gonzalez
Contribution of Individual Cytochrome P450 Isozymes to the O-Demethylation of the Psychotropic beta -Carboline Alkaloids Harmaline and Harmine
J. Pharmacol. Exp. Ther., April 1, 2003; 305(1): 315 - 322.
[Abstract] [Full Text]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 1970 by the American Society for Pharmacology and Experimental Therapeutics.